Form 4 for RNXT RenovoRx, Inc.
Accepted 2022-11-04 00:00:00 ET · period of report 2022-11-03 · accession 0001209191-22-055815 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-04 | 2022-11-03 | RNXT | Marton Laurence | Dir | M - OptEx | $1.70 | +25.4K | 25.4K | New | +$43.2K |
| D | 2022-11-04 | 2022-11-03 | RNXT | Marton Laurence | Dir | M - OptEx | $0.00 | -25.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-03 | M | A | 25,438 | $1.70 | 25,438 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-11-03 | M | D | 25,438 | $0.00 | 0 | D | $1.70 · — to 2023-04-02 | 25,438 Common Stock | (F1) Shares subject to the option are fully vested and immediately exercisable. |